Stocktoria

WORK Medical Technology Group LTD WOK

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023
Financials
Revenue$9.8M$11.5M$13.6M
Gross profit$2.3M$2.9M$4.1M
Net income-$1.1M-$3.5M$112,030
Operating cash flow$6.2M-$2.2M$2.2M
Free cash flow$4.9M-$11.5M$1.8M
Total assets$33.2M$36.3M$30.0M
Total liabilities$12.0M$20.2M$19.0M
Shareholders' equity$21.2M$13.2M$11.0M
Ratios
Gross margin23.8%24.9%30.5%
Net margin-10.9%-30.4%0.8%
FCF margin49.9%-99.5%12.9%
Return on assets-3.2%-9.6%0.4%
Return on equity-5.1%-26.5%1.0%
Current ratio1.711.031.17
Revenue growth-14.4%-15.2%

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001929783 · as of 2025-09-30. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.